
Contents
11 Oral factor Xa inhibitors
Get access-
Published:October 2023
Cite
Abstract
Oral factor Xa (FXa) inhibitors exert their antithrombotic effects and increase the risk of bleeding by their effects on the coagulation system. The oral direct FXa inhibitors are highly potent, reversible active-site inhibitors of FXa with good bioavailability, rapid onset, and used in a daily standard dose without laboratory monitoring. Dose adjustment is needed in relation to renal function. Three FXa inhibitors are registered for clinical use in the European Union for the prevention and treatment of venous thromboembolism and for the prevention of stroke in atrial fibrillation—rivaroxaban, apixaban, and edoxaban. The FXa inhibitors provide similar or better protection against venous thromboembolism and stroke than warfarin. In patients with atrial fibrillation there is improved long-term survival as compared with warfarin. Simultaneously, there is a much lower risk of intracranial bleeding and, with apixaban and edoxaban, also a lower risk of all bleeding than with warfarin. The treatment is cost-effective and preferred by most patients.
Signed in as
Institutional accounts
- National Science & Technology Library
- Capital Medical University
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMonth: | Total Views: |
---|---|
October 2023 | 2 |
December 2023 | 2 |
January 2024 | 3 |
February 2024 | 5 |
March 2024 | 2 |
April 2024 | 7 |
May 2024 | 5 |
June 2024 | 3 |
July 2024 | 3 |
August 2024 | 6 |
September 2024 | 1 |
December 2024 | 6 |
February 2025 | 3 |
March 2025 | 11 |
April 2025 | 1 |
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.